Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (4891)	7/15/1998 3:14:00 PM
From: Peter V	Read Replies (1) \| Respond to of 7041

Sell the news, currently in progress. I wonder how much is related to those waiting to short on the NDA filing?

To: Linda Kaplan who wrote (4891)	7/15/1998 3:18:00 PM
From: dino	Respond to of 7041

Now Linda, You would actually have to take a position and invest in order to buy these new shoes. It amazes me how one can take such pleasure in something they have no position in. Maybe your game is to pretend to invest in Zonagen?? Either way, this thread is blessed to have you as its perceived leader with your 20+ posts per day which include your kicking & screaming when someone contradicts them. Just another day on the calendar........

To: Linda Kaplan who wrote (4891)	7/15/1998 3:26:00 PM
From: Mark the K	Read Replies (1) \| Respond to of 7041

I am smiling when I see the price too. The chart was less obvious this time, but I should have bought a lot more puts when it became clear the NDA would finally be done...now they can dump. But my August puts will do just fine I guess... I really LOVE Zona. I have made so much on buying puts. When it went from 36+ down to low twenties 5-6 weeks ago, I pre-called it on yahoo board; the TA was so obvious. The H&S had formed, the candlesticks were just right for a tremendous drop. And I REALLY pissed off the hypester idiot longs there, bigtime. I checked in there today, someone was calling me names again, after the announcement -- and before the 2 + point drop. He was gloating that I couldn't gloat anyone, he hadn't taken the time to check the stock or waited til the s**t hit the fan... Best, Mark

To: Linda Kaplan who wrote (4891)	7/20/1998 4:04:00 PM
From: Mark the K	Read Replies (2) \| Respond to of 7041

Technical question: I have a technical question, this is to anyone, long or short. We all know that zonagen's phase III results show vasomax was effective for 51% of the men, 75% of the time, vs. placebo at 38% effective (also 75% of the time?) [I would have quoted from the Zonagen press release, but it was removed from my source]. This information was released on June 2 by Zonagen. Investors did not like these numbers, and the stock lost one third of its value. I have asked scientist friends about these numbers and I have gotten some chuckles but no real definitive answer about the numbers...to this question: Does anyone know what the FDA's past practices on approval are when comparing result to placebo result? Has any drug, with 51% vs. 38% for placebo, gotten approval, especially after they've given approval to a drug with better results? I REALLY WANT TO KNOW. While this might sound like a posed short question, if someone would point out drugs which got approval with these numbers, I think that shorts should beware. If someone could show an FDA pattern of disapproval of drugs with small increase over placebo like vasomax, then longs should beware. Forget the hype, I really don't care if Asensio or Podolski is a crook. I don't care if Viagra is dangerous, since I strongly doubt that the FDA takes that into account when studying vasomax, unless they plan to take Viagra off the market, which has zero likelihood. One person on yahoo said that stomache upset helpers, like pepcid, did barely better than placebo. Is this true? If so, what is the significance? If you know anything about fda approvals and do not want to be hassled here, email me at msk914@yahoo.com. And one more question: What is the guess on this qtr's earnings? Mark